BIVI BIOVIE INC

-

BIOVIE INC Reported Earnings

Friday, November 6, 2026 · 12:00 AM ET

BIOVIE INC (BIVI) reported a loss of $0.68 per share on revenue of $0.00 million for the . .

BioVie Inc. engages in developing drug therapies for liver disease. The company's product candidate includes BIV201, which are in clinical stage. BioVie Inc. is based in SANTA MONICA, CA.

Earnings Whisper Grade —
Power Rating—
Reported Earnings
($0.68)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth30.6 %
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth—